1. Vitamin B-6 Status Correlates with Disease Activity in Rheumatoid Arthritis Patients During Treatment with TNFα Inhibitors.
- Author
-
Sande JS, Ulvik A, Midttun Ø, Ueland PM, Hammer HB, Valen M, Apalset EM, and Gjesdal CG
- Subjects
- Adult, Arthritis, Rheumatoid blood, Biomarkers blood, C-Reactive Protein metabolism, Female, Humans, Kynurenine analogs & derivatives, Kynurenine blood, Longitudinal Studies, Male, Middle Aged, Pyridoxal Phosphate blood, Treatment Outcome, Tumor Necrosis Factor-alpha blood, Vitamin B 6 Deficiency blood, Xanthurenates blood, Arthritis, Rheumatoid drug therapy, Nutritional Status, Tumor Necrosis Factor Inhibitors therapeutic use, Tumor Necrosis Factor-alpha antagonists & inhibitors, Vitamin B 6 blood, Vitamin B 6 Deficiency complications
- Abstract
Background: A frequent observation in inflammatory conditions, including rheumatoid arthritis (RA), is low circulating amounts of pyridoxal 5'-phosphate (PLP), the metabolically active form of vitamin B-6. Recently, a functional marker of vitamin B-6 status, the ratio of 3-hydroxykynurenine (HK): xanthurenic acid (XA) in plasma (HK: XA), was proposed., Objective: We investigated vitamin B-6 status in patients with RA before and after established treatment with TNFα inhibitors., Methods: We performed a longitudinal study of RA patients (n = 106, 36% men, median age 54 y) starting first treatment with a TNFα inhibitor (infliximab, etanercept, adalimumab, golimumab, or certolizumab). Clinical assessment (Disease Activity Score for 28 standard joints, DAS28), joint ultrasonography, and blood draw were performed at baseline and after 3 mo treatment. Plasma concentrations of PLP, HK, and XA were measured by liquid chromatography-tandem mass spectrometry. Associations of changes in vitamin B-6 markers with change in DAS28 were assessed by generalized additive models regression and with European League Against Rheumatism (EULAR) response categories by linear regression., Results: At baseline PLP was inversely correlated with CRP (ρ = -0.27, P = 0.007), whereas HK: XA correlated with DAS28 (ρ = 0.46, P < 0.001), CRP (ρ = 0.36, P < 0.001), and ultrasonography scores (ρ = 0.29-0.35, P ≤ 0.003). After 3 mo treatment, the change (a 33% overall reduction) in DAS28 was related to changes in both PLP (ß = -0.28, P = 0.01) and HK: XA (ß = 0.33, P < 0.001). Good responders (45%) according to EULAR criteria experienced a 31% increase in PLP (P = 0.003) and an 11% decrease in HK: XA (P = 0.1), whereas nonresponders (24%) experienced a 25% increase in HK: XA (P = 0.02)., Conclusion: Two independent measures of vitamin B-6 status confirm an association with disease activity in RA patients. The association of HK: XA with disease activity may also imply perturbations in kynurenine metabolism in RA. This trial was registered at helseforskning.etikkom.no as 2011/490., (Copyright © American Society for Nutrition 2019.)
- Published
- 2019
- Full Text
- View/download PDF